stem cells in Europe
Muscular dystrophy Lgmd2a stem cell therapy Since 1998, we have been developing complex protocols for stem cell treatment of muscular dystrophy in order to overcome the limitations of traditional therapy. In our protocols, stem cells are combined with specialized therapy for muscular dystrophy, which not only focuses on helping the 阅读更多…
欧洲的注意力缺陷多动症干细胞疗法 欧洲的干细胞疗法显着改善了多动症的各种症状 多动症和刻板和重复的运动习惯显着减少. 感觉和运动功能得到改善. 注意力和注意力持续时间有所改善 阅读更多…
В чем разница между эмбриональными стволовыми клетками, эмбриональными стволовыми клетками и мезенхимальными стволовыми клетками? Вопросы? head_office@nbscience.com
问题 ? WhatsApp: +447778936902 , +33745637397, +34670491885 电子邮件: head_office@nbscience.com e-mail: head_office@nbscience.com
医学会议 2024 1) Congress of Oncologists and Radiologists 26-27 可能 2) World Health Day 07-08 April 2024 3) Current issues of cardiology 12 可能 2024 4) Psychiatric care 14-15 April 2024 5) Urgent cardiovascular conditions: multidisciplinary approach 02-03 六月 2024 6) Treatment of diseases of the nervous system 08-09 九月 阅读更多…
Autism stem cell therapy Generally, parents notice signs of Autism very early before age 2 或者 3. Mostly, motor milestones develop normally but delays can be observed. Parents might notice delays in speech and interactions or sometimes the speech develops but regresses thereafter. As brain functioning is heavily involved in 阅读更多…
